Litcius/Paper detail

Biowaste derived hydroxyapatite embedded on two-dimensional g-C3N4 nanosheets for degradation of hazardous dye and pharmacological drug via Z-scheme charge transfer

Govindasamy Palanisamy, Bhuvaneswari Kandasamy, T. Pazhanivel, Selvaraj Barathi, T. Maiyalagan, Mohd. Shkir, Jintae Lee

2022Scientific Reports78 citationsDOIOpen Access PDF

Abstract

Abstract In recent years, there has been an increase in demand for inexpensive biowaste-derived photocatalysts for the degradation of hazardous dyes and pharmacological drugs. Here, we developed eggshell derived hydroxyapatite nanoparticles entrenched on two-dimensional g-C 3 N 4 nanosheets. The structural, morphological and photophysical behavior of the materials is confirmed through various analytical techniques. The photocatalytic performance of the highly efficient HAp/gC 3 N 4 photocatalyst is evaluated against methylene blue (MB) and doxycycline drug contaminates under UV–visible light exposure. The HAp/gC 3 N 4 photocatalyst exhibit excellent photocatalytic performance for MB dye (93.69%) and doxycycline drug (83.08%) compared to bare HAp and g-C 3 N 4 nanosheets. The ultimate point to note is that the HAp/gC 3 N 4 photocatalyst was recycled in four consecutive cycles without any degradation performance. Superoxide radicals play an important role in degradation performance, which has been confirmed by scavenger experiments. Therefore, the biowaste-derived HAp combined with gC 3 N 4 nanosheets is a promising photocatalyst for the degradation of hazardous dyes and pharmacological drug wastes.

Topics & Concepts

Degradation (telecommunications)Hazardous wasteChemical engineeringNanoparticleMaterials scienceDrugChemistryComputer scienceNanotechnologyWaste managementPharmacologyTelecommunicationsMedicineEngineeringAdvanced Photocatalysis TechniquesAdvanced Nanomaterials in CatalysisNanoplatforms for cancer theranostics
Biowaste derived hydroxyapatite embedded on two-dimensional g-C3N4 nanosheets for degradation of hazardous dye and pharmacological drug via Z-scheme charge transfer | Litcius